04/22/2025 12:00 PM | Shuttle Pharmaceuticals (Filer)
| Form PRER14A | |
04/21/2025 3:15 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/21/2025 5:04 AM | Shuttle Pharmaceuticals (Filer)
| Form DEFR14A | |
04/10/2025 3:42 PM | Shuttle Pharmaceuticals (Filer)
| Form PRER14A | |
04/10/2025 3:05 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/02/2025 7:00 PM | Cooper Chris (Reporting) Shuttle Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
03/31/2025 4:25 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/31/2025 4:27 PM | Shuttle Pharmaceuticals (Filer)
| Form DEF 14A | |
03/31/2025 4:28 PM | Shuttle Pharmaceuticals (Filer)
| Form ARS | |
03/21/2025 7:00 PM | Nabyt Oleh (Reporting) Shuttle Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
03/21/2025 7:00 PM | Shuttle Pharmaceuticals (Issuer) Tung Joseph (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for SHPH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Shuttle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
03/21/2025 7:00 PM | Scorsis George (Reporting) Shuttle Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
03/19/2025 9:51 AM | Shuttle Pharmaceuticals (Filer)
| Form PRE 14A | |
03/13/2025 3:19 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/13/2025 5:36 AM | Shuttle Pharmaceuticals (Filer)
| Form 424B3 | |
03/12/2025 5:20 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/09/2025 11:15 PM | Shuttle Pharmaceuticals (Filer)
| Form EFFECT | |
03/05/2025 5:48 AM | Shuttle Pharmaceuticals (Filer)
| Form S-1/A | |
02/28/2025 4:24 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/27/2025 8:56 AM | Shuttle Pharmaceuticals (Filer)
| Form 424B3 | |
02/27/2025 8:58 AM | Shuttle Pharmaceuticals (Filer)
| Form 424B3 | |
02/27/2025 9:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 424B3 | |
02/27/2025 7:38 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/26/2025 9:45 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/26/2025 9:20 AM | Shuttle Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/13/2025 5:22 AM | Shuttle Pharmaceuticals (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
02/06/2025 6:33 PM | Richards Steven M (Reporting) Shuttle Pharmaceuticals (Issuer)
| Form 5/A | |
02/06/2025 6:34 PM | Schafer Joshua (Reporting) Shuttle Pharmaceuticals (Issuer)
| Form 5/A | |
02/05/2025 3:55 PM | Brown Milton (Reporting) Shuttle Pharmaceuticals (Issuer)
| Form 5 Annual statement of changes in beneficial ownership of securities | |
02/03/2025 6:30 PM | Richards Steven M (Reporting) Shuttle Pharmaceuticals (Issuer)
| Form 5 Annual statement of changes in beneficial ownership of securities | |
02/03/2025 6:30 PM | Schafer Joshua (Reporting) Shuttle Pharmaceuticals (Issuer)
| Form 5 Annual statement of changes in beneficial ownership of securities | |
01/24/2025 8:39 AM | Shuttle Pharmaceuticals (Filer)
| Form 424B3 | |
01/23/2025 11:15 PM | Shuttle Pharmaceuticals (Filer)
| Form EFFECT | |
01/21/2025 7:40 PM | Shuttle Pharmaceuticals (Filer)
| Form RW | |
01/21/2025 8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/15/2025 5:37 AM | Shuttle Pharmaceuticals (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
01/07/2025 8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/19/2024 8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/26/2024 8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2024 4:16 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2024 4:01 PM | Shuttle Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
Elon’s Terrifying Warning Forces Trump To Take Action (Ad) Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of collapse and built two of the most valuable companies in history.
Now, he's sounding the alarm about America's $36 trillion debt time bomb that could destroy the fabric of our society.As head of the Department of Government Efficiency (DOGE) under President Trump, Musk is exposing just how bad things are... Get your free gold guide! |
10/31/2024 7:57 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/31/2024 11:05 AM | Shuttle Pharmaceuticals (Filer)
| Form 424B4 | |
10/29/2024 11:15 PM | Shuttle Pharmaceuticals (Filer)
| Form EFFECT | |
10/29/2024 8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/28/2024 3:05 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/28/2024 8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/25/2024 7:49 AM | Shuttle Pharmaceuticals (Filer)
| Form D Notice of Exempt Offering of Securities | |
10/25/2024 7:52 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/18/2024 8:06 AM | Shuttle Pharmaceuticals (Filer)
| Form S-1/A | |
10/17/2024 4:17 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/09/2024 4:00 PM | Jung Mira (Reporting) Shuttle Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/20/2024 5:04 AM | Shuttle Pharmaceuticals (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
09/13/2024 7:25 PM | Shuttle Pharmaceuticals (Filer)
| Form 424B3 | |
09/13/2024 4:00 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/10/2024 4:23 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/04/2024 3:26 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/03/2024 8:51 PM | Shuttle Pharmaceuticals (Filer)
| Form 10-K/A | |
09/03/2024 8:52 PM | Shuttle Pharmaceuticals (Filer)
| Form 10-Q/A | |
09/03/2024 8:54 PM | Shuttle Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/28/2024 8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/13/2024 5:08 AM | Shuttle Pharmaceuticals (Filer)
| Form NT 10-Q | |
08/07/2024 7:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/01/2024 8:45 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/16/2024 3:59 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/25/2024 4:42 PM | Lorber Timothy J. (Reporting) Shuttle Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
06/18/2024 8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/10/2024 5:12 AM | Shuttle Pharmaceuticals (Filer)
| Form PRE 14A | |
05/22/2024 3:15 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/14/2024 8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/13/2024 4:01 PM | Shuttle Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |